V. Savci et al., EFFECT OF INTRACEREBROVENTRICULARLY INJECTED CHOLINE ON PLASMA ACTH AND BETA-ENDORPHIN LEVELS IN CONSCIOUS RATS, European journal of pharmacology, 309(3), 1996, pp. 275-280
In the present study, we examined the effect of intracerebroventricula
rly injected choline on plasma ACTH (adrenocorticotrophin) and beta-en
dorphin levels in conscious rats. The intracerebroventricularly inject
ion of choline (50-150 mu g) elevated plasma ACTH levels in a dose-dep
endent manner. Plasma beta-endorphin levels were also significantly in
creased. Pretreatment of rats with mecamylamine (50 mu g; intracerebro
ventricularly), the nicotinic receptor antagonist, completely inhibite
d the ACTH and beta-endorphin response to choline (150 mu g; intracere
broventricularly). An antagonist of the muscarinic receptor, atropine
(10 mu g; intracerebroventricularly), failed to alter these effects. P
retreatment of rats with hemicholinium-3 (20 mu g; intracerebroventric
ularly), a drug which inhibits the uptake of choline into cholinergic
neurons, abolished the choline-induced increases in both plasma ACTH a
nd beta-endorphin levels. These results indicate that choline can incr
ease plasma concentrations of ACTH and beta-endorphin through the acti
vation of central nicotinic acetylcholine receptors.